Hyaluronidase activity in serum of patients with monoclonal gammapathy.
Hyaluronidase and hyaluronic acid, two substances thought to be strongly implicated in carcinogenesis, were assessed in the plasma of 35 patients with newly documented monoclonal gammapathy and in 25 control patients. A significant increase was found in plasma hyaluronidase activity in the patients with monoclonal gammapathy. A statistically significant positive correlation was found between hyaluronidase activity and monoclonal immunoglobulin levels in plasma. An increase in serum hyaluronidase activities may be a response to the deleterious effect of hyaluronic acid in cell migration and tumor progression. Further studies are needed to assess the value of hyaluronidase activity as a marker of tumor progression.
Laudat
A
A
Laboratoire de Biochimie, Centre Hospitalier Général, B.P 407, 28018 Chartres, France. alaudat@ch-chartres.fr
Guechot
J
J
Lecourbe
K
K
Damade
R
R
Palluel
A M
AM
D000368:Aged; D005260:Female; D006801:Humans; D006820:Hyaluronic Acid / Q000097:blood; D006821:Hyaluronoglucosaminidase / Q000097:blood*; D008297:Male; D009101:Multiple Myeloma / Q000097:blood / Q000201:enzymology*; D008258:Waldenstrom Macroglobulinemia / Q000097:blood / Q000201:enzymology*
D006820:Hyaluronic Acid; D006821:Hyaluronoglucosaminidase